Eli Lilly is leading the market for GLP-1 medications (for weight loss and diabetes). In a decade, Eli Lilly could be in the ...
53mon MSN
Popular weight-loss drugs like Wegovy fail to lower obesity-related cancer risks, study finds
Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback